DOI : 10.1055/s-00000034

Klinische Pädiatrie

Issue 03 · Volume 230 · May 2018 DOI: 10.1055/s-008-39721

Kind-Philipp-Stiftung für pädiatrisch-onkologische Forschung
31. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung
Wilsede, Lüneburger Heide, 06.–09.06.2018

Wissenschaftliche Leitung: Prof. Dr. Martin Horstmann Prof. Dr. Martin Stanulla Prof. Dr. Rolf Marschalek Prof. Dr. Olaf Heidenreich

  • 28
    Müller, A; Afreen, S; Bohler, S; Rizzi, M; Schachtrup, K; Erlacher, M:

    Defining the role of Id2 in human erythropoiesis

  • 29
    Lopes, BA; Meyer, C; Duployez, N; Palmi, C; Alonso, C; Tsaur, G; Gupta, S; Marschalek, R; Emerenciano, M:

    The interplay between IKZF1 and COBL deletions in leukemia

  • 30
    Schönbeck, K; Winkler, A; Witthauer, MJ; Szymansky, A; Toedling, J; Schramm, A; Hertwig, F; Eggert, A; Schulte, JH:

    Hippo-YAP pathway activation favors neuroblastoma progression

  • 31
    Lenk, L; Vogiatzi, F; Carlet, M; Cario, G; Schrappe, M; Jeremias, I; Hobeika, E; Jumaa, H; Alsadeq, A; Schewe, DM:

    CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

  • 32
    Grabovska, Y; Finetti, MA; Selby, MP; Schwalbe, EC; Smith, A; Crosier, S; Pickles, JC; Fairchild, AR; Avery, A; O'Hare, P; Pizer, B; Brennan, B; Lowis, S; Hargrave, D; Anderson, J; Jacques, TS; Bailey, S; Clifford, SC; Williamson, D:

    Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

  • 33
    Molina, O; Agraz-Doblas, A; Roca-Ho, H; Pal, D; Granada, I; Rodríguez-Perales, S; Ballerini, P; Camos, M; Perez-Iribarne, MM; Plensa, I; Islam, A; Calasanz, MJ; Bueno, C; Menendez, P:

    Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

  • 34
    Finetti, MA; Ramli, R; Hacking, J; Ridgwell, D; Selby, MP; Grabovska, Y; del-Carpio Pons, A; Batting, S; Wood, JA; Barker, JM; Smith, A; Crosier, S; O'Hare, P; Pizer, B; Brennan, B; Lowis, S; Hargrave, D; Anderson, J; Jacques, TS; Bailey, S; Clifford, SC; Williamson, D:

    SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

  • 35
    Lutzny-Geier, G; Heydebrand, F von; Krumbholz, M; Metzler, M; Oostendorp, RAJ; Mackensen, A:

    Differences in stroma cell signaling after contact to acute lymphoblastic leukemia B-cells derived from adult and pediatric patients

  • 36
    Bock, M; Schönbeck, K; Toedling, J; Klironomos, F; Fuchs, S; Hundsdörfer, P; Eggert, A; Hertwig, F; Schulte, JH:

    Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

  • 37
    McKenzie, L; Martinez-Soria, N; Blair, HJ; Issa, H; Isa, A; Tirtakusuma, R; Bonifer, C; Heidenreich, O:

    The oncogenic transcription factor RUNX1/ETO corrupts the cell cycle to drive leukaemic transformation